JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 27, 2007; DOI: 10.1124/jpet.107.131565


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.131565v1
324/2/548    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masini, E.
Right arrow Articles by Salvemini, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masini, E.
Right arrow Articles by Salvemini, D.


Received for publication September 13, 2007.
Revised November 22, 2007.
Accepted for publication November 26, 2007.

Ceramide: A Key Signaling Molecule in a Guinea Pig Model of Allergic Asthmatic Response and Airway Inflammation

Emanuela Masini 1, Lucia Giannini 1, Silvia Nistri 1, Lorenzo Cinci 1, Rosanna Mastroianni 1, Wei Xu 2, Suzy AA Comhair 3, Dechun Li 2, Salvatore Cuzzocrea 4, George M Matuschak 2, Daniela Salvemini 2*

1 University of Florence 2 St Louis University 3 Cleveland Clinic, Cleveland USA 4 University of Messina

* Address correspondence to: E-mail: salvemd{at}slu.edu

Abstract

Although mechanisms involved in the pathogenesis of asthma remain unclear, roles for oxidative/nitrative stress, epithelial cell apoptosis and airway inflammation have been documented. Ceramide is a sphingolipid with potent proinflammatory and proapoptotic properties. This study aimed at determining whether increased formation of ceramide contributes to the development of airway inflammation and hyperresponsiveness, using a well characterized in vivo model of allergic asthmatic response and airway inflammation in ovalbumin-sensitized guinea pigs. Aerosol administration of ovalbumin increased ceramide levels and ceramide synthase activity in the airway epithelium, associated with respiratory abnormalities, such as cough, dyspnea and severe bronchoconstriction. These abnormalities correlated with nitrotyrosine formation in the airway epithelium and oxidative/nitrosative stress, epithelial cell apoptosis and airway inflammation evident by the infiltration of neutrophils and eosinophils in lung tissues, mast cell degranulation and release of prostaglandin D2 and proinflammatory cytokines. Inhibition of de novo ceramide synthesis with the competitive and reversible inhibitor of ceramide synthase fumonisin B1 (0.25, 0.5 and 1 mg/kg b.wt.), given i.p. daily for 4 days before allergen challenge, attenuated nitrotyrosine formation and oxidative/nitrosative stress, epithelial cell apoptosis and airway inflammation while improving the respiratory and histopathological abnormalities. These results implicate ceramide in the development of allergic asthmatic response and airway inflammation. Strategies aimed at reducing the levels of ceramide and downstream events should yield promising novel anti-asthmatic agents.


Key words: airway inflammation, apoptosis, ceramide, fumonisin B1, neutrophil infiltration, oxidative stress





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.